中药复方治疗青春期多囊卵巢综合征的研究进展
Research Progress of Traditional Chinese Medicine Compound in the Treatment of Adolescent Polycystic Ovary Syndrome
DOI: 10.12677/acm.2026.161178, PDF,   
作者: 赵 涵：黑龙江中医药大学研究生院，黑龙江 哈尔滨；张跃辉*：黑龙江中医药大学附属第一医院妇科，黑龙江 哈尔滨
关键词: 青少年；多囊卵巢综合征；中药复方；Adolescents； Polycystic Ovary Syndrome； Traditional Chinese Medicine Compounds
摘要: 多囊卵巢综合征(polycystic ovary syndrome, PCOS)是一种妇科复杂的内分泌疾病，多发生于青春期和育龄期女性。我国青春期PCOS患病率达到6%~18%，呈逐年增长趋势，未及时治疗纠正会出现育龄期生殖异常及其他系统并发症。一直以来西医治疗多为激素疗法，对于发育尚未成熟的青少年来说副作用较大，中医针对不同的青春期PCOS患者进行辨证论治，行中药治疗效果佳且副作用小。本文对于中药复方治疗青春期PCOS最新进展进行综述。
Abstract: Polycystic ovary syndrome (PCOS) is a complex gynecological endocrine disease, which mostly occurs in adolescent and childbearing age women. The prevalence of adolescent PCOS in China has reached 6%-18%, showing an increasing trend year by year. Without timely treatment and correction, reproductive abnormalities and other systemic complications will occur in childbearing age. For a long time, Western medicine treatment is mostly hormone therapy, which has great side effects for immature adolescents. Traditional Chinese medicine treats different adolescent PCOS patients based on syndrome differentiation, and traditional Chinese medicine treatment has good effect and small side effects. This article reviews the latest progress of traditional Chinese medicine compound in the treatment of adolescent PCOS.
文章引用：赵涵, 张跃辉. 中药复方治疗青春期多囊卵巢综合征的研究进展[J]. 临床医学进展, 2026, 16(1): 1383-1389. https://doi.org/10.12677/acm.2026.161178

参考文献

[1] Yang, R., Li, Q., Zhou, Z., Qian, W., Zhang, J., Wu, Z., et al. (2022) Changes in the Prevalence of Polycystic Ovary Syndrome in China over the Past Decade. The Lancet Regional Health—Western Pacific, 25, Article 100494. [Google Scholar] [CrossRef] [PubMed]
[2] Peña, A.S., Witchel, S.F., Hoeger, K.M., Oberfield, S.E., Vogiatzi, M.G., Misso, M., et al. (2020) Adolescent Polycystic Ovary Syndrome According to the International Evidence-Based Guideline. BMC Medicine, 18, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
[3] 苏椿淋, 林金芳. 青春期多囊卵巢综合征诊治策略[J]. 实用妇产科杂志, 2022, 38(10): 728-731.
[4] Manique, M.E.S. and Ferreira, A.M.A.P. (2022) Polycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management. Revista Brasileira de Ginecologia e Obstetrícia, 44, 425-433. [Google Scholar] [CrossRef] [PubMed]
[5] Saleh, F.L., Starkman, H., Furness, A., Pfeifer, S.M. and Kives, S. (2024) Polycystic Ovary Syndrome in Adolescents. Obstetrics and Gynecology Clinics of North America, 51, 679-693. [Google Scholar] [CrossRef] [PubMed]
[6] Burt Solorzano, C.M. and McCartney, C.R. (2021) Polycystic Ovary Syndrome: Ontogeny in Adolescence. Endocrinology and Metabolism Clinics of North America, 50, 25-42. [Google Scholar] [CrossRef] [PubMed]
[7] Itriyeva, K. (2022) The Effects of Obesity on the Menstrual Cycle. Current Problems in Pediatric and Adolescent Health Care, 52, Article 101241. [Google Scholar] [CrossRef] [PubMed]
[8] 高慧慧, 钱贝冉, 倪艳, 等. 多囊卵巢综合征发病机制研究进展[J]. 四川大学学报(医学版), 2024, 55(4): 1049-1054.
[9] Yadav, V. and Sharma, Y. (2023) Hyperandrogenism. Indian Journal of Pediatrics, 90, 1018-1024. [Google Scholar] [CrossRef] [PubMed]
[10] Armanini, D., Boscaro, M., Bordin, L. and Sabbadin, C. (2022) Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism. International Journal of Molecular Sciences, 23, Article 4110. [Google Scholar] [CrossRef] [PubMed]
[11] Calcaterra, V., Verduci, E., Cena, H., Magenes, V.C., Todisco, C.F., Tenuta, E., et al. (2021) Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients, 13, Article 1848. [Google Scholar] [CrossRef] [PubMed]
[12] Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W. and Xu, H. (2022) Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy. Signal Transduction and Targeted Therapy, 7, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
[13] Mizgier, M., Jarząbek-Bielecka, G., Wendland, N., Jodłowska-Siewert, E., Nowicki, M., Brożek, A., et al. (2021) Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome. Nutrients, 13, Article 896. [Google Scholar] [CrossRef] [PubMed]
[14] Velez, L.M., Seldin, M. and Motta, A.B. (2021) Inflammation and Reproductive Function in Women with Polycystic Ovary Syndrome. Biology of Reproduction, 104, 1205-1217. [Google Scholar] [CrossRef] [PubMed]
[15] Li, W., Liu, C., Yang, Q., Zhou, Y., Liu, M. and Shan, H. (2022) Oxidative Stress and Antioxidant Imbalance in Ovulation Disorder in Patients with Polycystic Ovary Syndrome. Frontiers in Nutrition, 9, Article 1018674. [Google Scholar] [CrossRef] [PubMed]
[16] Azim, S.S., Haque, Z., Khan, S., et al. (2024) Oxidative Stress in Polycystic Ovary Syndrome: A Case-Control Study. Journal of the Pakistan Medical Association, 74, S2-S7. [Google Scholar] [CrossRef] [PubMed]
[17] Mancini, A., Bruno, C., Vergani, E., d’Abate, C., Giacchi, E. and Silvestrini, A. (2021) Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights. International Journal of Molecular Sciences, 22, Article 1667. [Google Scholar] [CrossRef] [PubMed]
[18] Dapas, M., Lin, F.T.J., Nadkarni, G.N., Sisk, R., Legro, R.S., Urbanek, M., et al. (2020) Distinct Subtypes of Polycystic Ovary Syndrome with Novel Genetic Associations: An Unsupervised, Phenotypic Clustering Analysis. PLOS Medicine, 17, e1003132. [Google Scholar] [CrossRef] [PubMed]
[19] van der Ham, K., Moolhuijsen, L.M.E., Brewer, K., Sisk, R., Dunaif, A., Laven, J.S.E., et al. (2024) Clustering Identifies Subtypes with Different Phenotypic Characteristics in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 109, 3096-3107. [Google Scholar] [CrossRef] [PubMed]
[20] Bruni, V., Capozzi, A. and Lello, S. (2021) The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: The State of the Art. Reproductive Sciences, 29, 668-679. [Google Scholar] [CrossRef] [PubMed]
[21] 李琳, 杨冬梓. 青春期多囊卵巢综合征筛查与管理[J]. 中国实用妇科与产科杂志, 2019, 35(3): 291-295.
[22] Moore, J.M., Waldrop, S.W. and Cree-Green, M. (2021) Weight Management in Adolescents with Polycystic Ovary Syndrome. Current Obesity Reports, 10, 311-321. [Google Scholar] [CrossRef] [PubMed]
[23] Calcaterra, V., Magenes, V.C., Massini, G., De Sanctis, L., Fabiano, V. and Zuccotti, G. (2024) High Fat Diet and Polycystic Ovary Syndrome (PCOS) in Adolescence: An Overview of Nutritional Strategies. Nutrients, 16, Article 938. [Google Scholar] [CrossRef] [PubMed]
[24] Ibáñez, L. and de Zegher, F. (2023) Adolescent PCOS: A Postpubertal Central Obesity Syndrome. Trends in Molecular Medicine, 29, 354-363. [Google Scholar] [CrossRef] [PubMed]
[25] 张雯, 李娜, 许朝霞. 多囊卵巢综合征的中医证治研究进展[J]. 世界科学技术-中医药现代化, 2018, 20(5): 810-815.
[26] 王萍, 林辉, 黄群, 等. 补肾活络方治疗多囊卵巢综合征肾虚血瘀证的临床研究[J]. 北京中医药大学学报, 2013, 36(9): 637-639+644.
[27] 徐立平, 谢海平, 王萍, 等. 补肾活络方治疗青春期多囊卵巢综合征肾虚血瘀证的临床观察[J]. 中医药导报, 2018, 24(7): 75-77.
[28] 陆葳, 任青玲, 刘苏, 等. 补肾涤痰汤治疗青春期多囊卵巢综合征伴胰岛素抵抗患者临床观察[J]. 中药材, 2018, 41(3): 730-733.
[29] 李萍. 中医治疗肝经郁热型青春期多囊卵巢综合征的疗效探讨[J]. 中医临床研究, 2017, 9(28): 109-110.
[30] 薛春燕, 李程蕾, 顾乔, 等. 中医方药结合针灸治疗青春期多囊卵巢综合征患者的临床疗效观察[J]. 中医临床研究, 2020, 12(35): 91-93.
[31] 吴静, 梁若笳, 陈瑶. 痰湿型青春期多囊卵巢综合征患者临床特征与代谢指标的相关性研究[J]. 健康研究, 2022, 42(4): 469-472+476.
[32] 陈卉, 胡荣魁, 许家莹. 苍附导痰汤加减联合穴位贴敷治疗肥胖型青春期多囊卵巢综合征患者的疗效及对其体质量、代谢紊乱的影响[J]. 世界中西医结合杂志, 2025, 20(1): 181-187.
[33] 华宙佳, 王晨晔, 俞佳, 等. 基于网络药理学探讨苍附导痰汤加减方对多囊卵巢综合征大鼠胰岛素抵抗的作用机制[J]. 中国现代应用药学, 2023, 40(4): 461-470.
[34] 周丽娟, 潘丽贞. 健脾疏肝法治疗青春期多囊卵巢综合征48例[J]. 光明中医, 2017, 32(21): 3102-3104.
[35] 包蕊, 王馨, 韩欣. 参苓白术散调节txnip/nlrp3信号通路对多囊卵巢综合征大鼠胰岛素抵抗的影响[J]. 中国优生与遗传杂志, 2025, 33(8): 1703-1709.

为你推荐